After finishing at $3.03 in the prior trading day, Aurora Cannabis Inc (NASDAQ: ACB) closed at $2.90, down -4.29%. In other words, the price has decreased by -$0.1300 from its previous closing price. On the day, 1137377 shares were traded. ACB stock price reached its highest trading level at $3.0100 during the session, while it also had its lowest trading level at $2.8550.
Ratios:
Our goal is to gain a better understanding of ACB by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.45 and its Current Ratio is at 3.79. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.15.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACB now has a Market Capitalization of 158.30M and an Enterprise Value of 124.99M. As of this moment, Aurora’s Price-to-Earnings (P/E) ratio for their current fiscal year is 0.32. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.22 while its Price-to-Book (P/B) ratio in mrq is 0.35. Its current Enterprise Value per Revenue stands at 0.59 whereas that against EBITDA is -0.08.
Stock Price History:
Over the past 52 weeks, ACB has reached a high of $11.50, while it has fallen to a 52-week low of $2.97. The 50-Day Moving Average of the stock is 4.1080, while the 200-Day Moving Average is calculated to be 5.0746.
Shares Statistics:
The stock has traded on average 791.14K shares per day over the past 3-months and 1.4M shares per day over the last 10 days, according to various share statistics. A total of 34.53M shares are outstanding, with a floating share count of 15.68M. Insiders hold about 0.29% of the company’s shares, while institutions hold 30.39% stake in the company. Shares short for ACB as of Feb 15, 2024 were 3.55M with a Short Ratio of 4.49, compared to 3.68M on Jan 12, 2024.
Earnings Estimates
Its stock is currently analyzed by 2 different market analysts. On average, analysts expect EPS of -$0.17 for the current quarter, with a high estimate of -$0.04 and a low estimate of -$0.3, while EPS last year was -$1.48. The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.2 and low estimates of -$0.2.
Analysts are recommending an EPS of between -$0.07 and -$1.62 for the fiscal current year, implying an average EPS of -$0.93. EPS for the following year is -$0.32, with 3 analysts recommending between -$0.07 and -$0.73.
Revenue Estimates
4 analysts predict $51.73M in revenue for the current quarter. It ranges from a high estimate of $53.73M to a low estimate of $50.91M. As of the current estimate, Aurora Cannabis Inc’s year-ago sales were $46.86M, an estimated increase of 10.40% from the year-ago figure.
Based on 4 analysts’ estimates, the company’s revenue will be $236.32M in the next fiscal year. The high estimate is $249.38M and the low estimate is $224.07M. The average revenue growth estimate for next year is up 17.30% from the average revenue estimate for this year.
